INS and obstructive sleep apnea syndrome: For example, a randomized clinical trial comparing lifestyle modification with CPAP therapy in obese patients with moderate to severe OSA found that lifestyle-induced weight loss led to greater reductions in high-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation, and improved insulin sensitivity compared to CPAP alone.